# Maze Therapeutics, Inc. (MAZE)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/maze-therapeutics-inc/ JSON: https://steadybase.io/company/maze-therapeutics-inc.json Checked Nov 10, 2026. Latest filing read: Aug 11, 2026.

## Company

- Legal name: Maze Therapeutics, Inc.
- Ticker: MAZE (Nasdaq)
- SEC CIK: 0001842295
- Industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
- Headquarters: South San Francisco, CA
- Fiscal year ends: December 31
- SEC filer category: <br>Emerging growth company
- Website: mazetx.com
- Investor relations: https://ir.mazetx.com/
- LinkedIn: https://www.linkedin.com/company/mazetx
- Next earnings date: Nov 11, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $167.5M for the fiscal year ended Dec 31, 2024 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/0001193125-26-122778-index.html
- Operating income: -$142.9M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/0001193125-26-122778-index.html
- Net income: -$131.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/0001193125-26-122778-index.html
- SG&A: $34.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/0001193125-26-122778-index.html
- Employees: 141 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Shares outstanding: 54,683,345 as of Nov 4, 2026 (10-Q filed Nov 9, 2026). Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526453619/0001193125-26-453619-index.html
- Auditor: Ernst & Young LLP, San Mateo, California, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm

## Officers and directors

- Jason Coloma V., Chief Executive Officer. LinkedIn: https://linkedin.com/in/jasoncoloma. Source: Form 4 filed Sep 4, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000167617026000022/0001676170-26-000022-index.htm
- Misbah Tahir, Chief Financial Officer. LinkedIn: https://linkedin.com/in/misbahtahir. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Harold Bernstein, President, R&D & CMO. Source: Form 4 filed Sep 8, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000205017226000036/0002050172-26-000036-index.htm
- Hervé Hoppenot, Chairperson of our Board of Directors. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Atul Dandekar, CSBO. Source: Form 4 filed Sep 4, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000205016726000027/0002050167-26-000027-index.htm
- Phillips Courtney, GC and Corp. Secretary. Source: Form 4 filed Sep 4, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000178275826000008/0001782758-26-000008-index.htm
- Amy Bachrodt, SVP, Finance. LinkedIn: https://linkedin.com/in/amybachrodt. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000205042226000012/0002050422-26-000012-index.htm
- Catherine Angell Sohn, Pharm. D., Director. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Chan ges, in and Disagreements with Accountants on Accounting and Financial Disclosure. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Charles Homcy, M.D., Director. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Daniel Spiegelman, Director. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Jonathan Lim, M.D., Director. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Nancy C. Andrews, M.D., Ph.D., Director. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Neil Exter, Director. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- Richard Scheller, Ph.D., Director. Source: 10-K filed Mar 25, 2026, https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm

## Recent 8-K events

- Nov 9, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526453590/maze-20261109.htm
- Oct 16, 2026: Item 1.01, Entry into a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526424067/d445364d8k.htm
- Aug 17, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526354092/d135740d8k.htm
- Aug 11, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526344878/maze-20260811.htm
- Jun 10, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526265858/d110541d8k.htm
- May 22, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526237199/d909749d8k.htm
- May 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526219398/maze-20260512.htm
- Apr 22, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526170701/d115741d8k.htm
- Mar 25, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122774/maze-20260324.htm
- Feb 4, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.03, Creation of a direct financial obligation. Source: https://www.sec.gov/Archives/edgar/data/1842295/000119312526037747/d34522d8k.htm

## Insider trades (Form 4)

- Nov 2, 2026: Jason Coloma V. (Chief Executive Officer) sold 34,501 shares, about $1.0M. Source: https://www.sec.gov/Archives/edgar/data/1842295/000167617026000026/0001676170-26-000026-index.htm
- Oct 29, 2026: Atul Dandekar (CSBO) sold 7,500 shares, about $240,532. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205016726000032/0002050167-26-000032-index.htm
- Oct 1, 2026: Harold Bernstein (President, R&D & CMO) sold 16,141 shares, about $434,743. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205017226000038/0002050172-26-000038-index.htm
- Oct 1, 2026: Jason Coloma V. (Chief Executive Officer) sold 34,501 shares, about $932,260. Source: https://www.sec.gov/Archives/edgar/data/1842295/000167617026000024/0001676170-26-000024-index.htm
- Sep 29, 2026: Atul Dandekar (CSBO) sold 7,500 shares, about $202,921. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205016726000030/0002050167-26-000030-index.htm
- Sep 4, 2026: Harold Bernstein (President, R&D & CMO) sold 9,705 shares, about $254,465. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205017226000036/0002050172-26-000036-index.htm
- Sep 3, 2026: Harold Bernstein (President, R&D & CMO) sold 10,295 shares, about $270,111. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205017226000034/0002050172-26-000034-index.htm
- Sep 3, 2026: Atul Dandekar (CSBO) sold 6,434 shares, about $168,811. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205016726000027/0002050167-26-000027-index.htm
- Sep 3, 2026: Phillips Courtney (GC and Corp. Secretary) sold 3,993 shares, about $104,766. Source: https://www.sec.gov/Archives/edgar/data/1842295/000178275826000008/0001782758-26-000008-index.htm
- Sep 3, 2026: Jason Coloma V. (Chief Executive Officer) sold 22,638 shares, about $593,955. Source: https://www.sec.gov/Archives/edgar/data/1842295/000167617026000022/0001676170-26-000022-index.htm
- Sep 1, 2026: Harold Bernstein (President, R&D & CMO) sold 16,141 shares, about $425,477. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205017226000032/0002050172-26-000032-index.htm
- Sep 1, 2026: Jason Coloma V. (Chief Executive Officer) sold 34,501 shares, about $907,083. Source: https://www.sec.gov/Archives/edgar/data/1842295/000167617026000020/0001676170-26-000020-index.htm
- Aug 28, 2026: Atul Dandekar (CSBO) sold 7,500 shares, about $206,850. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205016726000023/0002050167-26-000023-index.htm
- Aug 13, 2026: Harold Bernstein (President, R&D & CMO) sold 16,142 shares, about $445,681. Source: https://www.sec.gov/Archives/edgar/data/1842295/000205017226000028/0002050172-26-000028-index.htm
- Aug 3, 2026: Jason Coloma V. (Chief Executive Officer) sold 34,501 shares, about $922,190. Source: https://www.sec.gov/Archives/edgar/data/1842295/000167617026000016/0001676170-26-000016-index.htm

## Latest filings

- 8-K filed Oct 16, 2026: https://www.sec.gov/Archives/edgar/data/1842295/000119312526424067/d445364d8k.htm
- 10-K filed Mar 25, 2026: https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm
- 10-Q filed Aug 11, 2026: https://www.sec.gov/Archives/edgar/data/1842295/000119312526344903/maze-20260630.htm
- DEF 14A filed Apr 28, 2026: https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/